Peptide and Oligonucleotide CDMO Market Size & Share Analysis - Growth, Trends and Forecasts (2024 - 2029)

The Peptide and Oligonucleotide CDMO Market Report is Segmented by Product (Peptide CDMO and Oligonucleotide CDMO), Application (Therapeutics, Research Applications, Diagnostics, and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Contract Research Organizations (CROs), and Academic and Government Organizations). The Report Offers the Value (in USD) for the Above Segments.

Peptide and Oligonucleotide CDMO Market Size & Share Analysis - Growth, Trends and Forecasts (2024 - 2029)

Peptide And Oligonucleotide CDMO Industry Overview

The market for peptide and oligonucleotide contract development and manufacturing organizations is moderately competitive, with both small and large players involved in strategic activities such as the expansion of services, partnerships, collaborations, as well as mergers, and acquisitions. Key players are Thermo Fisher Scientific Inc., Polypeptide Group, Wuxi Apptec Co. Ltd, Genscript Biotech Corporation, and CordenPharma International.

Peptide And Oligonucleotide CDMO Market Leaders

  1. Thermo Fisher Scientific Inc.

  2. Polypeptide Group

  3. Wuxi Apptec Co., Ltd.

  4. Genscript Biotech Corporation

  5. CordenPharma International

  6. *Disclaimer: Major Players sorted in no particular order
Peptide And Oligonucleotide CDMO Market Concentration

Peptide And Oligonucleotide CDMO Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?